Trending...
- IDEMIA Awarded 10-Year Blanket Purchase Agreement from the General Services Administration for Next-Generation Identity Proofing for Login.Gov - 315
- Sarah Novotny Joins Kosai as a Board Advisor: A New Chapter for Open Source Leadership
- NY Implant Dentistry - Dr. Greg R. Diamond, DDS – Your Trusted Dentist in NYC, New York
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ASP Isotopes To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 in ASP Isotopes between October 30, 2024 and November 26, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, Jan. 2, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ASP Isotopes Inc. ("ASP Isotopes" or the "Company") (NASDAQ: ASPI) and reminds investors of the February 3, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
More on Nyenta.com
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company overstated the potential effectiveness of its enrichment technology; (2) the Company overstated the development potential of its high assay low-enriched uranium facility; (3) the Company overstated the Company's nuclear fuels operating segment results; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
On November 26, 2024, Fuzzy Panda Research published a report which alleged that ASP Isotopes is "using old, disregarded laser enrichment technology to masquerade as a new, cutting-edge Uranium enrichment." The report quoted a former employee of Klydon (the company ASP Isotopes purchased its "proprietary" technology from) as stating scientists "did not think it would work on Uranium." The report revealed a series of experts interviewed stated the Company's reported cost estimates and timeline for building its HALEU uranium facilities was misleading to the point of being "delusional." The report further alleged the Company had significantly overstated the significance of its agreement with TerraPower, which was only a "non-binding" memorandum of understanding entered into to "put pressure on [TerraPower's] real suppliers." The report quoted a former TerraPower executives as stating that ASP Isotopes was "missing the manufacturing; They are missing the processes as well; They still have to develop the HALEU…the most important part." Finally, the report revealed that the Company's subsidiary, Quantum Leap Energy, which operates its nuclear fuels segment and to which the Company assigned the TerraPower memoranda of understanding, was completely absent from its registered South African address. The report revealed there were "zero signs" of their presence and "security guards and neighboring business about them all told us they had never heard of the companies."
More on Nyenta.com
On this news, the Company's stock price fell $1.80 or 23.53%, to close at $5.85 per share on November 26, 2024, on unusually heavy trading volume.
The stock continued to fall on the subsequent trading date, falling $0.83 or 14.19%, to close at $5.02 per share on November 27, 2024, on unusually heavy trading volume.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding ASP Isotopes' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the ASP Isotopes class action, go to www.faruqilaw.com/ASPI or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
SOURCE Faruqi & Faruqi, LLP
If you suffered losses exceeding $50,000 in ASP Isotopes between October 30, 2024 and November 26, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, Jan. 2, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ASP Isotopes Inc. ("ASP Isotopes" or the "Company") (NASDAQ: ASPI) and reminds investors of the February 3, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
More on Nyenta.com
- Exciting News: Gourmet Meal Kiosks Coming to Wilmorite Malls in Rochester, NY!
- Holistic Energy Bodyworks Launches New Website to Transform Wellness
- Yonkers: HOLLYWOOD ON HUDSON: YONKERS FILM AND TELEVISION PRODUCTION SOARS IN 2024
- Genuine Hospitality, LLC Expands Leadership Team with Key Appointments
- TilePix x Jonathan Adler Introduce The Jet Set Collection
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company overstated the potential effectiveness of its enrichment technology; (2) the Company overstated the development potential of its high assay low-enriched uranium facility; (3) the Company overstated the Company's nuclear fuels operating segment results; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
On November 26, 2024, Fuzzy Panda Research published a report which alleged that ASP Isotopes is "using old, disregarded laser enrichment technology to masquerade as a new, cutting-edge Uranium enrichment." The report quoted a former employee of Klydon (the company ASP Isotopes purchased its "proprietary" technology from) as stating scientists "did not think it would work on Uranium." The report revealed a series of experts interviewed stated the Company's reported cost estimates and timeline for building its HALEU uranium facilities was misleading to the point of being "delusional." The report further alleged the Company had significantly overstated the significance of its agreement with TerraPower, which was only a "non-binding" memorandum of understanding entered into to "put pressure on [TerraPower's] real suppliers." The report quoted a former TerraPower executives as stating that ASP Isotopes was "missing the manufacturing; They are missing the processes as well; They still have to develop the HALEU…the most important part." Finally, the report revealed that the Company's subsidiary, Quantum Leap Energy, which operates its nuclear fuels segment and to which the Company assigned the TerraPower memoranda of understanding, was completely absent from its registered South African address. The report revealed there were "zero signs" of their presence and "security guards and neighboring business about them all told us they had never heard of the companies."
More on Nyenta.com
- New-and-Improved Caribbean-Food Website Dishes Out Free Ground-Shipping Offer; Affiliate Program Garnished with Generous Commission
- 50th Mount Dora Arts Festival set for Feb 1 and 2, 2024
- CCHR Cites Newly Released Mind Control Records to Oppose Psychedelics
- K2 Integrity Appoints Markus Schulz as Chief Technology Officer
- LINE FRIENDS and HoYoverse to Debut Genshin minini POP-UP at LINE FRIENDS Flagship Store in New York City's Times Square Starting January 22nd
On this news, the Company's stock price fell $1.80 or 23.53%, to close at $5.85 per share on November 26, 2024, on unusually heavy trading volume.
The stock continued to fall on the subsequent trading date, falling $0.83 or 14.19%, to close at $5.02 per share on November 27, 2024, on unusually heavy trading volume.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding ASP Isotopes' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the ASP Isotopes class action, go to www.faruqilaw.com/ASPI or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
SOURCE Faruqi & Faruqi, LLP
Filed Under: Business
0 Comments
Latest on Nyenta.com
- LIB: A master of ingenuity in the field of custom test chambers, unlocking unlimited possibilities!
- Anatomage Announces Acquisition of Cloud-based Software Company BioDigital
- PRP Aviation Earns Prestigious "Platinum Cirrus Training Center" Designation
- SHAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger - SDIG, IPXX, KAVL, ML
- New Rochelle Job Fair at City Hall, Wednesday, January 22
- Richard Contino's 'Equipment Leasing and Financing' A Manufacturer's Guide to Captive Financing
- MongoDB, Inc. to Present at the 27th Annual Needham Growth Conference
- Growth Marshal Publishes Comprehensive Guide to Content Marketing for CEOs
- Cyrus Webb and Conversations Media Group Providing New Opportunities for Authors and Creatives to Shine and Thrive
- Tam Tam Named Best Children's Music Education & Wellness Organization in New York
- Westchester Network for Professionals Launches Exclusive New Year Membership Offer
- Seeking Sponsors for the BizNetwork Destination Tours Launch Party & Networking Social Gala
- Inframark Acquires Cornerstone Properties, Inc., Expanding Community Management Services in Arizona
- Loose, Uncomfortable Dentures? Get a Same-Day Reline While-U-Wait!
- IDEMIA Awarded 10-Year Blanket Purchase Agreement from the General Services Administration for Next-Generation Identity Proofing for Login.Gov
- New Report Highlights Opportunities and Barriers in Finger Lakes Clean Energy Workforce
- Rochester: Statement by Mayor Evans regarding life of President Jimmy Carter on National Day of Mourning
- NY Implant Dentistry - Dr. Greg R. Diamond, DDS – Your Trusted Dentist in NYC, New York
- ITURAN ANNOUNCES PARTICIPATION IN UPCOMING CONFERENCES IN JANUARY 2025
- SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against BioAge Labs, Inc. - BIOA